KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Exchange Rate Effect (2016 - 2025)

Thermo Fisher Scientific's Exchange Rate Effect history spans 17 years, with the latest figure at -$6.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Exchange Rate Effect rose 97.8% year-over-year to -$6.0 million, compared with a TTM value of $267.0 million through Dec 2025, up 393.41%, and an annual FY2025 reading of $267.0 million, up 393.41% over the prior year.
  • Exchange Rate Effect for Q4 2025 was -$6.0 million at Thermo Fisher Scientific, up from -$75.0 million in the prior quarter.
  • The five-year high for Exchange Rate Effect was $311.0 million in Q2 2025, with the low at -$273.0 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is $7.4 million, with a median of -$10.5 million recorded in 2024.
  • Year-over-year, Exchange Rate Effect tumbled 2830.0% in 2024 and then surged 2173.33% in 2025.
  • Tracing TMO's Exchange Rate Effect over 5 years: stood at $211.0 million in 2021, then grew by 18.48% to $250.0 million in 2022, then tumbled by 96.0% to $10.0 million in 2023, then tumbled by 2830.0% to -$273.0 million in 2024, then skyrocketed by 97.8% to -$6.0 million in 2025.
  • Per Business Quant, the three most recent readings for TMO's Exchange Rate Effect are -$6.0 million (Q4 2025), -$75.0 million (Q3 2025), and $311.0 million (Q2 2025).